#lpcn1154 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #lpcn1154, aggregated by home.social.
-
DATE: September 15, 2026 at 10:17AM
SOURCE: PSYCHIATRIC TIMESDirect article link at end of text block below.
Lipocine has announced the initiation of the phase 3 Brexanolone Lifting Outcomes of Moms (BLOOM) study evaluating LPCN 1154 for postpartum depression. The first participant is expected to be dosed in early Q4 2026. https://t.co/RbStn272oy
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #PostpartumDepression #BLOOMStudy #LPCN1154 #Brexanolone #Phase3ClinicalTrial